An additional study by Heitzemeder et al. with CAR T cells demonstrated again that overexpression of jun results in significant improvement in potency and persistence, in this case against neuroblastoma, without apparent off-target toxicity [98]. This evidence concerns the gene JUN and neuroblastoma.